​
​

Vanda Pharmaceuticals Ownership | Who Owns Vanda Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Vanda Pharmaceuticals Ownership Summary

Vanda Pharmaceuticals is owned by 75.38% institutional investors, 3.16% insiders, and 21.46% retail investors. Blackrock is the largest institutional shareholder, holding 14.09% of VNDA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.99% of its assets in Vanda Pharmaceuticals shares.

VNDA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVanda Pharmaceuticals75.38%3.16%21.46%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.74M2.99%-
iShares Russell 2000 ETF1.46M2.51%-3.29K
Vanguard Institutional Extnd Mkt Idx Tr898.43K1.54%19.34K
International Biotechnology Ord844.00K1.45%-311.42K
BlackRock Advantage Small Cap Core Instl833.46K1.43%133.70K
Federated Hermes MDT Small Cap Core IS624.55K1.07%-
Federated Hermes MDT SCC Institutional624.55K1.07%-
Fidelity Small Cap Index579.11K0.99%-14.01K
iShares Russell 2000 Value ETF532.66K0.91%-
Nuveen Quant Small Cap Equity R6530.50K0.91%166.10K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 14, 2024Mitchell Stephen Ray-Sell$25.86K
Jul 29, 2024Moran Kevin Patrick SVP, CFO & TreasurerSell$13.33K
Mar 05, 2024Williams Timothy SVP & General CounselSell$37.40K
Mar 04, 2024Williams Timothy SVP & General CounselSell$35.92K
Mar 05, 2024Wijkstrom Joakim SVP, Chief Marketing OfficerSell$38.83K

Insider Transactions Trends

DateBuySell
2024 Q3-1
2024 Q2--
2024 Q1-10
2023 Q3-4
2023 Q2-2

VNDA Ownership FAQ

Who Owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals shareholders are primarily institutional investors at 75.38%, followed by 3.16% insiders and 21.46% retail investors. The average institutional ownership in Vanda Pharmaceuticals's industry, Biotech Stocks , is 45.35%, which Vanda Pharmaceuticals exceeds.

Who owns the most shares of Vanda Pharmaceuticals?

Vanda Pharmaceuticals’s largest shareholders are Blackrock (8.14M shares, 14.09%), Renaissance (4.11M shares, 7.12%), and Vanguard group (3.43M shares, 5.94%). Together, they hold 27.15% of Vanda Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vanda Pharmaceuticals?

Yes, BlackRock owns 14.09% of Vanda Pharmaceuticals, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 45.98M$. In the last quarter, BlackRock decreased its holdings by -1.629K shares, a -0.02% change.

Who is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Profit investment management is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.02% of its assets in 571.32K Vanda Pharmaceuticals shares, valued at 3.23M$.

Who is the top mutual fund holder of Vanda Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vanda Pharmaceuticals shares, with 2.99% of its total shares outstanding invested in 1.74M Vanda Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools